Robert F. Kennedy Jr., who awaits confirmation as Donald Trump's Health and Human Services secretary, helped organize mass ...
Prostate cancer has proved an elusive target for cancer immunotherapies, and Merck & Co's checkpoint inhibitor Keytruda is the latest to fall short in the disease in a phase 3 trial. Merck has ...
WASHINGTON (AP) — Robert F. Kennedy Jr., the controversial environmental lawyer turned public health critic, is set to find ...
Investor's Business Daily on MSN1d
Dow Jones Giant Merck Beats Quarterly Expectations. But Will Its Light Guidance Slug Shares?Merck topped Wall Street's fourth-quarter expectations Tuesday, but Merck stock could take a hit on lighter-than-expected 2025 sales guidance.
An upcoming critical test for this strategy is Roche’s handling of Phesgo against biosimilar IV Perjeta, which will provide insights into Merck’s potential success in oncology life cycle ...
Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los Angeles court next week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback